scholarly journals Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study

2017 ◽  
Vol 177 (2) ◽  
pp. 419-427 ◽  
Author(s):  
H. Saeki ◽  
K. Kabashima ◽  
Y. Tokura ◽  
Y. Murata ◽  
A. Shiraishi ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease

2014 ◽  
Vol 89 (7) ◽  
pp. 709-713 ◽  
Author(s):  
Marvin E. Reid ◽  
Amal El Beshlawy ◽  
Adlette Inati ◽  
Abdullah Kutlar ◽  
Miguel R. Abboud ◽  
...  
Keyword(s):  
Sickle Cell Disease ◽  
Sickle Cell ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Efficacy And Safety ◽  
Cell Disease ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document